Sign In
Get Clay Free →

Suggestions

    Mario Marchesi

    CAR-T Marketing & Sales Assoc. Director at Novartis

    Mario Marchesi is a senior executive at Novartis, currently serving as the Rare Disease Lead for LACan (STA).4 He has extensive experience in the pharmaceutical industry, particularly in gene therapy and rare diseases. Throughout his career at Novartis, Marchesi has held several leadership positions, including:

    1. Director of CAR-T marketing, sales, and operations4
    2. Hematology group marketing manager4
    3. Director of Gene Therapy35

    Marchesi is known for his expertise in innovative therapies, particularly in the field of CAR-T therapy, which involves genetically reprogramming a patient's immune cells to target cancer cells.2 He has also been involved in discussions about the treatment of Atrofia Muscular Espinhal (AME) type I using Zolgensma, a gene therapy product developed by Novartis.1

    In his current role, Marchesi is actively involved in addressing challenges related to rare disease treatments, including issues of access and affordability. He has been vocal about the importance of early diagnosis and treatment in conditions like AME, emphasizing the potential for improved patient outcomes and reduced healthcare costs.1

    Highlights

    Zolgensma: pacientes buscam tratamento via judicialização
    A novel non-transcriptional pathway mediates the proconvulsive ...

    Related Questions

    What are Mario Marchesi's main responsibilities at Novartis?
    How has Mario Marchesi contributed to the marketing and sales of CAR-T therapies?
    What is Mario Marchesi's background before joining Novartis?
    How does Mario Marchesi's role impact the accessibility of treatments like Zolgensma?
    What challenges has Mario Marchesi faced in his career at Novartis?
    Mario Marchesi
    Add to my network

    Location

    São Paulo, São Paulo, Brazil